Aeovian Pharma Raises $55M For Novel mTORC1 Inhibitor
16 Dec 2025 //
BUSINESSWIRE
Aeovian First Doses in Ph 1 Trial and Raises Additional $50 Million Financing
28 Mar 2024 //
PR NEWSWIRE
Aeovian Pharmaceuticals brings in $37 million in mTOR play
03 Oct 2019 //
ENDPTS

Market Place
Sourcing Support